Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-3-3
pubmed:abstractText
Takayasu arteritis (TA) is a chronic vasculitis of unknown etiology. Experience with anti-tumor necrosis factor alpha (anti-TNF) agents in difficult-to-treat patients with TA is limited and refers to adult patients. Here, we present two cases of pediatric TA treated with infliximab, in which clinical remission was observed. Anti-TNF treatment represents a useful therapy in pediatric Takayasu arteritis too, especially to avoid the risk of long-term corticosteroids toxicity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1437-160X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
93-5
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Infliximab therapy in pediatric Takayasu's arteritis: report of two cases.
pubmed:affiliation
Division of Rheumatology, Department of Pediatrics, Ospedale Pediatrico Bambino Gesù, IRCCS, Piazza S. Onofrio, 4, 00135 Rome, Italy. psabrina.buonuomo@opbg.net
pubmed:publicationType
Journal Article, Case Reports